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Abstract
Background:  Many cellular multi-protein complexes are naturally present in cells at low
abundance. Baculovirus expression offers one approach to produce milligram quantities of
correctly folded and processed eukaryotic protein complexes. However, current strategies suffer
from the need to produce large transfer vectors, and the use of repeated promoter sequences in
baculovirus, which itself produces proteins that promote homologous recombination. One possible
solution to these problems is to construct baculovirus genomes that express each protein in a
complex from a separate locus within the viral DNA. However current methods for selecting such
recombinant genomes are too inefficient to routinely modify the virus in this way.
Results: This paper reports a method which combines the lambda red and bacteriophage P1 Cre-
recombinase systems to efficiently generate baculoviruses in which protein complexes are
expressed from multiple, single-locus insertions of foreign genes. This method is based on an 88
fold improvement in the selection of recombinant viruses generated by red recombination
techniques through use of a bipartite selection cassette. Using this system, seven new genetic loci
were identified in the AcMNPV genome suitable for the high level expression of recombinant
proteins. These loci were used to allow the recovery two recombinant virus-like particles with
potential biotechnological applications (influenza A virus HA/M1 particles and bluetongue virus
VP2/VP3/VP5/VP7 particles) and the mammalian chaperone and cancer drug target CCT (16
subunits formed from 8 proteins).
Conclusion: 1. Use of bipartite selections can significantly improve selection of modified bacterial
artificial chromosomes carrying baculovirus DNA. Furthermore this approach is sufficiently robust
to allow routine modification of the virus genome. 2. In addition to the commonly used p10 and
polyhedrin loci, the ctx, egt, 39k, orf51, gp37, iap2 and odv-e56 loci in AcMNPV are all suitable for
the high level expression of heterologous genes. 3. Two protein, four protein and eight protein
complexes including virus-like particles and cellular chaperone complexes can be produced using
the new approach.
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Background
The baculovirus Autographa califonica multiple nucleopolyhe-
drosis virus (AcMNPV) is routinely used to express proteins
in eukaryotic cells for structural, biochemical and vaccine
studies [1]. The AcMNPV genome is circular dsDNA (~134
kb) and contains regions of highly repetitive DNA ele-
ments and genes in both strands [2]. This genomic DNA
can be propagated in Escherichia coli as a bacmid, and
genes can be inserted by Tn7 transposase based transposi-
tion into the virus DNA [3]. Transfection of the modified
bacmid DNA into virus susceptible insect cells results in
recovery infectious virus expressing the recombinant pro-
tein corresponding to the inserted gene [3]. Alternate
approaches in which homologous recombination is car-
ried out in insect cells can also be used to generate recom-
binant baculoviruses [4,5].
One of the advantages of the baculovirus system is its util-
ity for the co-expression of multiple genes that encode
protein complexes [6-12]. This is important, as many crit-
ical functions of living cells are carried out by multi-subu-
nit protein complexes which are naturally present at low
abundance. One approach for the baculovirus mediated
co-expression of multiple genes is the insertion of expres-
sion cassettes as tandem or inverted repeats at the polyhe-
drin locus in the viral genomic DNA [6-9,12,13]. This
approach ensures that every cell in the culture expresses
the genes encoding recombinant proteins in the same
ratio and results in consistent yields of recombinant pro-
tein complex [14]. However, this approach has two major
limitations. Firstly, there is a practical limit to the number
of genes that can be inserted into one transfer vector in
terms of vector size. In practice, this means that it is rarely
possible to express more than four proteins from a single
locus. In addition, baculovirus expresses proteins that
promote homologous recombination [15-17], therefore
viruses that contain large amounts of repeated sequences,
such as common promoters and terminators, are prone to
rearrangement and recombination [11,18,19]. A potential
solution to these problems would be the production of
viral genomes in which foreign genes are each expressed
from a different genetic locus, removing the need for large
transfer vectors with highly repetitive sequences. How-
ever, to date, most baculovirus expression experiments
have been carried out with one of two loci (polyhedrin
and p10). There have also been reports of v-cath [10,11]
being used to express heterologous proteins, but the
expression of foreign genes from other loci in the genome
is largely uncharacterised. Therefore, before any multi-
locus approach to express genes for larger complexes
could be pursued it would be necessary to characterise for-
eign gene expression at alternative loci within the AcM-
NPV genome.
Recently baculovirus research has benefited from use of
the lambda red recombination [20] approach for selective
knockout of viral genes [21-28]. However, the potential
for this technique to engineer high level expression of for-
eign genes from different genetic loci within the baculovi-
rus genome has not been examined. In this report, we
describe high level expression of foreign genes from seven
loci within the AcMNPV genome not previously character-
ised for this purpose. Furthermore, we demonstrate a
functional multi-locus system for the expression of multi-
ple foreign genes from a single baculovirus genome. In
this system single protein expression cassettes are inserted
efficiently at different loci within the viral genome using
lambda red recombination. As single-gene insertions are
thus distributed throughout the AcMNPV genome, the
problems of transfer vector size and highly repetitive
inserts are overcome. We demonstrate the utility of this
system for the expression of complexes with up to eight
subunits using influenza A VLPs (2 proteins), bluetongue
VLPs (4 proteins) and the essential mammalian chaper-
onin complex CCT (8 proteins) as examples.
Results
A bipartite selection system allows significant increase in 
the efficiency of recombinant bacmid recovery
Lambda red recombination [20] has been widely used to
introduce knockout mutations in AcMNPV [21-28]. In the
majority of these experiments a chloramphenicol resist-
ance gene has been used as a selectable marker. In our
hands, although this system worked, the speed with
which experiments could be completed was hampered by
the number of false positive colonies arising due to the
low levels of antibiotic used in selection of the low copy
bacmid. Also, it was not possible to introduce multiple
modifications into the virus genome without either accu-
mulating antibiotic resistance genes or performing
another round of lambda red recombination and select-
ing for virus which had lost the selectable marker. To over-
come these problems we designed a new bipartite
selection cassette based on LacZα fragment and Zeocin
resistance gene flanked by modified loxP recombination
sites (Fig. 1A). Using this system, sufficient Zeocin was
used to reduce, but not eliminate, background colony
growth and recombinants were selected based on blue
colony phenotype in the presence of IPTG and X-gal.
To assess the relative efficiency of recovering recom-
binants using the chloramphenicol and bipartite selec-
tions, recombination competent E. coli containing
unmodified AcMNPV bacmid were electroporated with
30 ng (~12.5 fmol) linear DNA containing each selection
cassette (Fig. 1B). The efficiency of recombination using
PCR derived and plasmid derived, restriction enzyme
released, linear DNA was compared. PCR primers were
designed such that the ends of the PCR products corre-
sponded to the ends of the restriction enzyme released
fragments. The bipartite selection resulted in a 21 fold
increase in the number of positive colonies for PCRBMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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Bipartite selection provides significant increase in selection efficiency for lambda red Bacmid recombination Figure 1
Bipartite selection provides significant increase in selection efficiency for lambda red Bacmid recombination. 
A) Two recombination cassettes were designed, both with baculovirus flanking sequences (AcMNPV), p35 promoter (Pp35), 
Renilla Luciferase (R-luc) and polyhedrin polyadenylation sequences (Tph) and LoxP sites flanking a bacterial selectable marker. 
For bipartite selection (top) a Zeocin resistance gene (ZeoR) and LacZα marker were incorporated. For single marker selec-
tion (bottom) the cat gene, conferring chloramphenicol resistance, was incorporated. B) The number of positive colonies fol-
lowing red recombination using 30 ng of each recombination cassette (~12.58 fmol), generated either by PCR amplification or 
restriction enzyme digestion, and BACmid DNA. Each transformation was carried out in triplicate, error bars indicate the 
standard deviation of the results. The data for the two different selections were clustered and a t-test used to confirm that the 
results were statistically significant (p = 0.03). C) PCR confirming recombination and correct target site 12 independent bacmid 
recombinants (lanes 1-12). One primer annealed to genomic DNA flanking the target insertion site and the other to sequence 
inside the recombination cassette. Only recombination at the correct genetic locus would produce the PCR product 
(arrowed). Lane 13, no template PCR reaction; Lane 14, bMON14272 Bacmid template DNA; Lane 15 plasmid containing the 
entire DNA used for recombination as template. D) Renilla luciferase activity at 48 hours post infection in cell lysates from 
cells infected with passage 2 of recombinant bacmids 1-12 from B. Cells and AcMNPV indicate background activity in lysates 
from uninfected and unmodified bacmid infected cells, respectively.BMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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derived DNA and an 88 fold increase for restriction
enzyme released plasmid DNA compared to the single
antibiotic selection. These differences were significant (t-
test, p = 0.03). To avoid repeated PCR of coding
sequences, and to take advantage of the increased effi-
ciency of recombination, linear DNA derived by restric-
tion digestion of plasmid DNA was used for subsequent
experiments.
PCR was carried out on bacmid DNA purified from posi-
tive colonies from the bipartite selection to confirm cor-
rect insertion of the expression construct. Primers
complementary to the zeocin resistance gene and the
AcMNPV DNA flanking the correct insertion site were
used. PCR product was only produced where correctly tar-
geted recombination had occurred. DNA for twelve sepa-
rate bacmids were tested using this method (Fig. 1C, lanes
1-12), all were positive for the PCR product, indicating
correctly targeted recombination. In contrast, neither bac-
mid DNA alone, nor plasmid DNA containing the DNA
fragment used for recombination was able to act as tem-
plate to produce the PCR product (Fig. 1C, lanes 14 and
15 respectively). To test the viability of recombinant bac-
ulovirus, the same twelve PCR positive bacmid clones
were transfected into Sf9 cells and passaged twice, then
Renilla luciferase activity in cells infected with each of the
recombinants was assayed at 48 hours post infection.
Cells infected with each of the twelve recombinant viruses
had Renilla luciferase activities that were 106 fold above
background (Fig. 1D). Based on these data the bipartite
selection was used for further studies. The genetic locus
used for these initial studies was the p10 locus, which was
modified to remove native p10  promoter sequences.
Cre mediated removal of the selectable marker allows 
multiple rounds of recombination with the same bipartite 
selection
In order to engineer multiple insertions in the AcMNPV
genome, the bipartite selection cassette was flanked by
modified loxP sites. These sites incorporated both the
lox66 and lox71 mutations that limit Cre mediated recom-
bination to a single round [29], and a mutation in the
spacer reducing homology to the wildtype loxP site. Cre
mediated recombination would thus result in the removal
of the bipartite selectable marker and inactivation of the
lox recombination sites but leave behind the baculovirus
expression cassette (Fig. 2A). To confirm this strategy
could be used successfully to engineer multiple insertions
in the bacmid DNA, Cre recombination was used to
remove the bipartite marker from bacmid in which the
renilla luciferase reporter had been inserted. Bacmid DNA
was purified from four putative recombinants and recom-
bination confirmed by PCR using primers flanking the
selectable marker (Fig. 2B). All four PCR products were
consistent with the size expected for successful Cre recom-
bination. This was further confirmed by sequencing across
the modified loxP site of the recombinants (Fig. 2C). To
confirm that Cre mediated bacmid recombinants
remained viable in insect cells, bacmid DNA was trans-
fected into insect cells and luciferase activity assayed after
two passages as before. All recombinants had renilla luci-
ferase activity that was equivalent to the parental baculo-
virus before Cre recombination (Fig. 2D).
Identification of genetic loci in the baculovirus genome 
suitable for high level expression of heterologous genes
To test whether the new selection could be used efficiently
at different baculovirus genetic loci a second round of
recombination was carried out using one of the bacmids
already containing the renilla luciferase gene. A second
reporter, firefly luciferase, under control of the polyhedrin
promoter was inserted at a total of thirteen different
genetic loci (ctx, orf11, egt, orf23, v-fgf, 39k, orf51, gp37,
iap2, chiA, pe, odv-e18 and odv-e56), in each case generat-
ing a dual expression baculovirus for Renilla and firefly
luciferase (Fig. 3A). Additional changes were made at cer-
tain loci to specifically inactivate the expression of the
endogenous viral gene (Fig. 3B). Recombinant viruses
were passaged twice in Sf9 insect cells and on the third
passage cells were harvested at 48 hours post infection,
lysed and assayed for both firefly and Renilla luciferase
activities. Renilla luciferase activity was used as a reference
for virus replication and protein expression as all the
recombinants had the same P35 promoter driven Renilla
luciferase cassette in the p10 locus. Expression of firefly
luciferase at each locus was compared to a virus carrying
firefly luciferase gene at the polyhedrin locus. Of the thir-
teen loci tested, nine had renilla luciferase activities which
were at least 105 fold above background, and of these
eight (ctx, egt, orf51, gp37, iap2, chiA, odv-e18 and odv-e56)
had renilla luciferase activity which was equivalent to that
of the parental renilla luciferase only control (Fig. 3C).
Thus there was no evidence of a general impairment in
virus replication or gene expression for these viruses. In
contrast, four insertions (orf11, v-fgf, pe and orf23) resulted
in virus infections where renilla luciferase activity was
within 10 fold of the background and were exluded from
further analysis.
Renilla luciferase activity was used as a reference to nor-
malise firefly luciferase activity and obtain a measure of
relative expression of the firefly luciferase from each locus
(Fig. 3D). Seven loci (ctx, egt, 39k, orf51, gp37, iap2 and
odv-e56) had firefly luciferase activity which was at least
106 fold higher than background and similar to polyhe-
drin locus expression of the gene (Fig. 3D). Two viruses
(chiA and odv-e18) had high levels of renilla luciferase but
relatively poor firefly luciferase activity suggesting that
although these viruses were capable of replication, expres-
sion of the polyhedrin promoter driven reporter at this
locus was impaired.BMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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Selective removal of marker genes Figure 2
Selective removal of marker genes. A) Cartoon showing strategy for Recombineering of an expression cassette (expres-
sion) into the AcMNPV Bacmid DNA and selective removal of only the marker genes (selection) by Cre mediated recombina-
tion. B) PCR using primers labelled a and b in A using: Lanes 1-2, two independent bacmid recombinants following red 
recombination; Lanes 3-6, four independent recombinants following Cre mediated recombination to remove the bacterial 
selectable markers; Lane 7, no template; Lane 8, unmodified bacmid DNA template; Lane 9, plasmid DNA template containing 
the selectable marker cassette; Lane 10, DNA marker. PCR products corresponding to the sizes predicted for the parental and 
recombinant products of the Cre mediated recombination are labelled P and R respectively. C) Sequencing trace file of a rep-
resentative recombinant from the PCR analysis in B confirming the presence of a defective loxP incorporating the loxP71 and 
loxP66 arms that render the recombinant incapable of undergoing further Cre-mediated recombination. D) Renilla luciferase 
activity of the parental and recombinant bacmids from B when transfected into insect cells. Renilla luciferase activity was 
assayed at 48 hours post infection after on passage 2 of the recombinant virus. Background activity from uninfected cells is 
labelled Cells.BMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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Identification of additional sites for expression of recombinant proteins in the AcMNPV genome Figure 3
Identification of additional sites for expression of recombinant proteins in the AcMNPV genome. A) Genome of 
AcMNPV showing relative locations of loci used for protein expression. Bars inside the genome indicate position of hr 
sequences. B) Table showing loci used for insertion and any additional changes made to locus. KO indicates knockout. C) Rel-
ative renilla luciferase activity at 48 hours post infection with virus modified to contain an additional firefly luciferase expression 
cassette at each locus indicated. All viruses had the same renilla luciferase expression cassette at the p10 locus under control 
of the p35 promoter. Error bars indicted the standard deviation of five replicates for each locus. D) Normalised firefly luci-
ferase activity showing relative expression of a polyhedrin promoter-polyhedrin terminator inserted at each locus as indicated. 
Error bars indicate the standard deviation from 5 replicates for each locus. Firefly luciferase was normalised using the renilla 
luciferase control expressed from the same genome. Firefly luciferase insertions at the orf11, v-fgf, pe and orf23 loci were 
excluded due to renilla luciferase levels more than 2 logs lower than positive control virus. Virus Ph has firefly luciferase at the 
polyhedrin locus and renilla luciferase at the p10 locus. Virus Ph* has the same p10 renilla luciferase insertion but no firefly luci-
ferase insertion.BMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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There was no clear correlation between the position of a
locus within the virus genome and its ability to allow suc-
cessful high level expression of the foreign reporter gene
(Additional file 1: Figure S1). Nor was there any correla-
tion between the level of expression observed for the
reporter and that documented for the native gene at the
same locus [30].
Simultaneous co-expression of two and four genes to 
recover virus-like particles
To confirm that the system could successfully express and
correctly assemble protein complexes, two well defined
virus-like particle (VLP) systems were used as models.
VLPs were produced for influenza A virus by co-expressing
the M1 and HA proteins of the SC35M strain of influenza
[31]. M1 was first inserted at the egt locus and then, fol-
lowing removal of the bipartite cassette, the HA gene was
inserted into the p10 locus (Fig. 4A). Expression of both
proteins was confirmed by SDS-PAGE and Immunoblot
analysis (Fig. 4A, left and middle panels) using antibody
specific for Influenza A (H7N7). Furthermore, it was pos-
sible to purify influenza VLPs from the culture medium of
Sf9 cells infected with the recombinant baculovirus. The
surface of these VLPs had the characteristic spike appear-
ance of an enveloped virus (Fig. 4A, right panel) and it was
possible to label these spike structures using immunogold
labelling with anti-influenza (H7N7) antibody.
The other VLP made was for the non-enveloped orbivirus,
bluetongue virus. VLPs for this virus require the coassem-
bly of four proteins (VP2, VP3, VP5 and VP7). Expression
of recombinant protein was confirmed by SDS-PAGE
analysis (Fig. 4B, left panel) and VLPs with the character-
istic morphology of mature BTV particles could be puri-
fied from insect cells infected with recombinant
baculovirus (Fig. 4B, right panel).
Coexpression of eight genes to recover the mouse CCT 
complex
To extend our observations further, and to demonstrate
the utility of the muli-locus expression system to the pro-
duction of large mammalian protein complexes, the eight
subunits of the mouse CCT chaperonin complex (CCT1 to
CCT8, respectively) were each expressed from a different
locus within the baculovirus genome (Fig. 5A.). All eight
subunits were expressed and accumulated in insect cells to
detectable levels, although there was a variation in the
steady-state levels of protein between subunits. Expressed
protein was detected with a polyclonal antibody against a
conserved motif of the ATP-binding site of all CCT subu-
nits (Fig. 5A middle panel). There was cross reaction
between the antibody and some of the subunits of the
endogenous insect CCT complex, and it was impossible to
confirm the presence of CCT8. To confirm mouse CCT8
was expressed, a duplicate immunoblot was probed with
a monospecific antibody to the CCT8 protein (Fig. 5A bot-
tom panel). These data confirmed all eight CCT subunits
were expressed using the multi-locus expression
approach.
The native CCT chaperone complex consists of a hexa-
decamer arranged as two stacked rings of 8 subunits
[32,33]. To confirm formation of a complex for the
recombinant mouse CCT subunits, we performed rate-
zonal centrifugation in 10-40% (w/w) sucrose gradients.
The characteristic protein profile for the CCT complex was
Expression of virus like particles Figure 4
Expression of virus like particles. A) Influenza A VLPs. 
Left and middle, stained SDS-PAGE and immunoblot, respec-
tively, of cells expressing; Lane 1, Influenza HA (p10locus) 
and M1 (egt locus); Lane 2, Influenza HA (p10 locus) only; 
Lane 3, uninfected cells; Lane 4, Influenza M1 (egt locus). The 
immunoblot was probed with a polyclonal anti-influenza 
(H7N7) antibody. Right panel negative stain electron micro-
graphs of influenza VLPs purified from the culture medium of 
infected cells. Bar = 50 nm. In the lower panel white arrows 
indicate the position of 5 nm gold particles labelling the HA 
spikes of the VLPs. B) Bluetongue virus VLPs. Left, stained 
SDS-PAGE of lysate from cells infected with AcMNPV 
expressing: Lane 1, BTV-1 VP5 (p10 locus); Lane 2, BTV-
1VP2 (odv-e56 locus); Lane 3, BTV-1 VP3 (polyhedrin locus); 
Lane 4, BTV-1 VP7 (gp37 locus); Lane 5, Semipurified VLPs 
recovered from a virus coexpressing all 4 BTV proteins; M, 
marker lanes with proteins of defined mass. Right hand pan-
els, electron micrographs of negatively stained BTV VLPs. Bar 
= 50 nm.BMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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Recovery of recombinant mouse CCT complex by co-expression of 8 proteins in the same insect cell Figure 5
Recovery of recombinant mouse CCT complex by co-expression of 8 proteins in the same insect cell. A) Top 
panel, cell lysates from cells expressing mouse CCT subunits 1-8 (lanes 1-8, respectively). Lane 9, uninfected cells; Lane 10, 
lysate from cells coexpressing the CCT subunits from the same baculovirus genome; M, marker protein lane. Relative migra-
tion of CCT subunits is indicated on the left hand side of the gel. Loci used in the expression were CCT1-polyhedrin, CCT2-
p10, CCT3-egt, CCT4-39K, CCT5-gp37, CCT6-odv-e56, CCT7-ctx, CCT8-orf51. Middle panel, Immunoblot using pan-specific 
antiserum against mouse CCT, sample order as in top panel. Bottom panel, Immunoblot using monospecific antiserum against 
mouse CCT theta (CCT8), sample order as in top panel. B) Fractions 12 to 22 (of 34) numbered from the top of a 10%-
40%(w/w) sucrose gradient. CCT complex proteins peak in the expected ratio in fractions 16 and 17. Relative migrations 
expected for the CCT proteins are indicated on the left of the gel. Middle panel, immunoblot using pan-specific antiserum 
against mouse CCT subunits. Lower panel, electron micrographs of negatively stained sample from the 23.5S peak fraction col-
lected from the sucrose gradient. Ring structures consistent with CCT complexes can be detected. Bar = 25 nm.BMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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detected as a peak following centrifugation (Fig. 5B, top
panel lanes 16-17). The identity of these proteins as CCT
subunits was confirmed by immunoblotting (Fig. 5B,
middle panel). The averaged migration of this complex in
the gradient over 3 experiments was consistent with a sed-
imentation coefficient of 23.5 +/- 1.1S and was similar to
that reported for the native mouse CCT complex[32].
Finally, fractions corresponding with the 23.5S recom-
binant mouse CCT complex were visualised by negative
staining and electron microscopy (Fig. 5B, bottom panel).
It was possible to visualise ring-like structures consistent
with those reported with the mouse CCT[32].
Discussion
This report demonstrates that lambda red recombination
can be used to efficiently engineer high level expression of
recombinant protein and protein complexes from the
AcMNPV genome. Using a new bipartite selection system
up to 88 fold improvement (p = 0.03) in recovery of
recombinants was achieved. All putative recombinants
recovered using the bipartite selection were subsequently
confirmed to be correctly modified. This is a substantial
improvement over the single antibiotic selection [21,28]
which in our hands produced a high level of false positive
recombinants (recombinants that were apparently chlo-
ramphenicol resistant but subsequently did not have the
target insertion). Furthermore, there was no requirement
to use PCR generated linear DNA for recombination,
which avoids potential problems associated with muta-
tions introduced by repeated PCR of coding regions. To
our knowledge the bipartite selection in this report has
not previously been applied to recombination in baculo-
virus, although there have been reports of the zeocin
resistance gene alone being used for knock out of baculo-
virus genes by lambda red recombination[34].
By flanking the ZeoR-LacZα selection with self inactivating
loxP sites it was possible to re-use the selectable markers
and carry out iterative selection at multiple loci within the
baculovirus genome (Fig. 2). This iterative process itself
allows the potential for combining several different subu-
nits into the same baculovirus genome in different combi-
nations without having to generate a new multi-gene
transfer vector for every combination of proteins that is to
be expressed.
Despite the extensive protein expression work that has
been undertaken in the baculovirus system most expres-
sion has focussed on replacement of the polyhedrin or
p10 genes. Relatively little literature describes the use of
alternative loci for the expression of recombinant protein
[10,35-37]. This study identifies seven genetic loci (ctx,
egt, 39k, orf51, gp37, iap2 and odv-e56), in addition to pol-
yhedrin and p10, suitable for high level expression of for-
eign genes.
For the loci that did not give good expression, four (orf11,
v-fgf, pe and orf23) also resulted in a reduced expression of
a separate marker protein present in all recombinants.
This suggests that these insertions resulted in impairment
of functions essential for virus replication or gene expres-
sion. The low level expression of firefly luciferase expres-
sion in the chiA  and  odv-e18  insertion viruses was
unexpected for different reasons. Other reports have
recorded insertion of recombinant protein expression cas-
settes into the chiA locus [10,11]. It is possible that the
reduced level of firefly luciferase expression from this
locus in our experiments was due to effects on genes flank-
ing the insertion. For odv-e18, recent reports based on
deletion within the coding sequence of odv-e18 and the
upstream flanking gene have suggested that this protein is
essential for budded virus production and cell to cell
movement [38,39]. In our experiments, where odv-e18
was inactivated by specific mutation of the start codon
and by insertion of the firefly luciferase cassette, there was
no evidence from renilla luciferase expression of impair-
ment of the ability of this mutant virus to replicate or
spread cell to cell. However, given the ~2 log reduction in
firefly luciferase levels compared to virus without this
insertion, we cannot rule out the possibility that a small
population of virus in which the mutation had reverted
was complementing the virus expressing the reporter
gene.
To confirm the utility of the system for the expression of
recombinant protein complexes two-protein and four-
protein virus like particles (VLPs) were produced to influ-
enza A and bluetongue virus, respectively. VLPs for both
these viruses are effective immunogens against the respec-
tive pathogen [40-42] and thus represent potential bio-
technological applications of the multi-locus expression
approach. Both VLPs were formed normally and could be
purified from the culture medium (for influenza VLPs), or
cells (for BTV), of baculovirus infected cultures. To extend
these observations further and to demonstrate the useful-
ness of the approach to low abundance mammalian pro-
tein complexes we expressed all eight subunits of the
mouse CCT complex. This complex is usually purified
from testes or by large scale fermentation culture of yeast
[32,43,44]. However a reliable source of large quantities
of correctly folded recombinant mammalian CCT com-
plex was not previously available. It was possible to
recover between 1 and 6 mg/L culture of 23.5S CCT com-
plex. To our knowledge this is the first report of the suc-
cessful expression of mammalian CCT chaperone from a
heterologous system, and offers for the first time the pos-
sibility of mutational analysis of this essential machinery
involved in cytoskeletal protein folding and cell cycle con-
trol.
In addition to providing the opportunity for assembly of
multiprotein complexes, the multilocus system also offersBMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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the opportunity to test and manipulate relative expression
of each subunit of a complex independently, without any
need for recloning into different transfer vectors, and for
swapping subunits between complexes, also without need
for recloning. Thus, in terms of flexibility, it offers sub-
stantial improvement over the current approaches for bac-
ulovirus multi-protein complex expression.
Conclusion
1. Use of bipartite selections can significantly improve
selection of modified bacterial artificial chromosomes
carrying baculovirus DNA. Furthermore this approach is
sufficiently robust to allow routine modification of the
virus genome. 2. In addition to the commonly used p10
and polyhedrin loci, the ctx, egt, 39k, orf51, gp37, iap2 and
odv-e56 loci in AcMNPV are all suitable for the high level
expression of heterologous genes. 3. Two protein, four
protein and eight protein complexes including virus-like
particles and cellular chaperone complexes can be pro-
duced using the new approach.
Methods
Cell Lines and Virus
Sf9 and Sf21 cells were cultured at 28°C in Insect-Xpress
(Lonza, Basel, Switzerland) and TC100 media (Biochrom
AG, Berlin, Germany), respectively. All cells were rou-
tinely cultured in the presence of penicillin (100 U)/strep-
tomycin (100 μg/ml)/Amphotericin B (250 ng/ml)
(Sigma-Aldrich Chemical Co., St. Louis, Mo.). TC100
medium was supplemented with 10% Foetal bovine
serum. Viruses used in this study were based on the cloned
AcMNPV genome [3]. For recombinants where protein
was expressed from the polyhedrin locus, the
BAC10:KO1629 bacmid [28] was used, for all other
expressions a modified version of the bacmid
bMON14272 [3] in which the expression of the LacZα
fragment had been inactivated was used.
Antibodies
Polyclonal anti influenza H7N7 antibody was a gift from
H.D. Klenk (University of Marburg). The pan-CCT anti-
body, UM1, and the monospecific CCT8 antibody used
were as described [45]. Anti rabbit immunogold antibody
was purchased from Sigma-Aldrich. Negative staining was
with 2% (w/v) uranyl acetate. All immunoblotting was
performed using Immobilon P membrane (Millipore,
Billerica, MA) according to the manufacturer's instruc-
tions.
Construction of transfer vectors
Base expression and selection cassettes with the structure
detailed in Fig. 1A, but without flanking AcMNPV were
constructed in pBluescript SK (Stratagene, Cedar Creek,
Texas). Transfer vectors targeting the different genetic loci
within baculovirus were constructed by the general strat-
egy of amplification and cloning of the corresponding
region of the AcMNPV genome followed either by muta-
genesis to introduce a restriction enzyme site, allowing
insertion of the base expression and selection cassette, or
digestion with restriction enzymes to introduce the same
cassette. Details of the primers and restriction enzymes
used for each locus are detailed in table 1. All constructs
were designed such that a linear DNA fragment contain-
ing the AcMNPV flanking sequences and the expression
and selection cassettes could be released by digestion with
BsaI. Where possible, for each locus the expression and
selection cassettes were inserted in both orientations and
firefly luciferase monitored independently in each orien-
Table 1: Primers used for amplification of sequences for each AcMNPV locus used and restriction enzyme site used for insertion of 
reporter and expression cassettes.
Locus Forward Primer Reverse primer Restriction enzymes used
ctx CACTTGACTCGATTGCGCG TATTTATTGTCTACATGAACACG m*EcoRV
orf11 GTTGCACCTTTGACGAAGCGG TCACAATCCATAACACACAACAGG m* EcoRV
egt ATGTGCGACCATTGTTGGGC GTTGTCACATCTGACTACTCC pd
orf23 AGAGTGCGTTAATCTGTACACC ATCATAGGGTACAACACAGG StuI/SfoI
v-fgf CCGGCAAAATCAAAGCGAGC GATTACACGTGACATTTACGATGG m* EcoRV
39k CCTGGTAATTTTTGACCACG CGCAGCAATTCCAGCGAGC m* EcoRV
orf51 AAATGACTAGACAAGAAATTGCC AGTTGTACAAATCACAAATATAAAAG BmgBI
gp37 ATTGACGGGCCGTCGGCACG CGATCATGCAAAAGTACATGC m* EcoRV
iap2 CCGCGGCTAAGCGTTAAACC TTCGAATACGTGTGTCGTTTAATTTGC BstBI/SacII
chiA TAAACGCTCCGACTCTGTGG CGAGGGCCGCGGCCAGTGGGTC pd
pe GCATTTTTCCAATGTGGTAGACG CTTTAGCGGTTTCCAACGCC m* EcoRV
odv-e18 TCTCAAACACGGTGCCTGC TCGTTGGTTTCAGTGACCAC m* EcoRV
odv-e56 CAACATGACGCCGCTGCCG TTATCGAGGGGCCGTTGTTG m* EcoRV
m*EcoRV, indicates that an EcoRV site was engineered by site directed mutagenesis using the quickchange site directed muagenesis system 
(Stratagene) according to the manufacturer's directions. Pd indicates that a deletion was engineered by PCR. In the case of the egt locus this 
deletion removes the equivalent of nt 11622-12474 nt in the AcMNPV genome. For chiA the engineered deletion removes the chiA and cathepsin 
genes and is positioned nt 105461-107946 nt in the AcMNPV genome.BMC Molecular Biology 2009, 10:87 http://www.biomedcentral.com/1471-2199/10/87
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tation. For protein expression experiments the coding
sequence of each gene was amplified from a cDNA clone
of the respective gene and cloned downstream of the pol-
yhedrin promoter into the same vectors. For CCT the com-
plete set of mouse CCT cDNAs [46] were used.
Luciferase assays
All luciferase assays were completed using the Dual Luci-
ferase Reporter Assay system (Promega, Madison, USA)
using a Turner Biosciences 20/20 n luminometer accord-
ing to the manufacturer's instructions.
Lambda red recombination in E. coli
All bacmids were maintained in the E. coli strain EL350
[47] which was grown at 32°C. Expression of the λ bet, exo
and gam genes in this lysogen were induced by incubation
at 42°C for a 30 minute period immediately harvesting
cells for the preparation of batches of cells for electropo-
ration. Once prepared, electrocompetent cells were stored
at -80°C prior to use. For lambda red recombination 30
ng linear DNA was introduced into recombination com-
petent cells by electroporation. Cells were grown for two
hours at 32°C and then plated under Kanamycin (50 μg/
ml) Zeocin (15 μg/ml) and IPTG/X-gal (0.2 mM and 40
μg/ml respectively). For modification of BAC10:KO1629
chloramphenicol selection (15 μg/ml) was also included.
Plates were incubated at 32°C and blue colonies picked to
seed liquid cultures after 24 hours. All preparation of
DNA was performed according to standard molecular
techniques [48].
Cre recombination in E. coli
Expression of Cre recombinase in EL350 was induced by
treatment of mid-log phase cultures with 0.1% Arabinose
for 2 hours followed by a change of media and outgrowth
for 16 hours at 32°C. Cells were then plated on selective
media containing IPTG (0.2 mM), X-Gal (40 μg/m) and
kanamycin (50 μg/ml). White colonies were re-streaked
onto the same selection after 24 hours and then used to
seed liquid cultures.
Purification of VLPs
Bluetongue VLPs were purified from infected Sf9 cells as
described [7]. Influenza A (HA/M1) VLPs were purified
from the culture medium of infected Sf9 cells at 72 hours
post infection. Culture medium was clarified by spinning
at 9500 × g for 10 minutes at 4°C before being spun onto
a 60% w/v sucrose cushion for 1 hour at 90,000 × g at 4°C
in a SW28 rotor to concentrate VLPs. Material on top of
the sucrose cushion was then diluted six fold in PBS and
loaded onto a 20%-30%-60% (w/w) sucrose step gradient
before being spun again for 1 hour at 90,000 × g at 4°C in
a SW28 rotor. Material at the 30-60% sucrose interface
contained the particles shown in Fig. 5.
Purification of CCT
Sf21 cells were infected with recombinant baculovirus at
multiplicity of infection of 3 and harvested at 48-72 hours
post infection. Cells were washed in PBS and lysed at
room temperature in lysis buffer (50 mM HEPES pH8.0,
100 mM NaCl, 0.05% (v/v) Tergitol NP-9). Nuclei were
pelleted at 1000 × g for 5 minutes then cell debris pelleted
at 9500 × g for 10 minutes at 4°C. Clarified cell lysate was
spun at 100,000 × g at 4°C for 1 hour then serially filtered
through 0.5 μm, 0.2 μm and 0.05 μm filters (Pall, East
Hills, NY and Spectrum Laboratories, Breda, The Nether-
lands). Filtered lysate was concentrated using a centriplus
filtration device (Millipore, Billerica, MA) with a 100 kDa
cut-off. Concentrated lysate was loaded onto 10-40% (w/
w) continuous sucrose gradients in 50 mM Hepes pH8.0,
100 mM NaCl and spun for 16 hours at 4°C at 30,000
rpm in a SW40 rotor. Following centrifugation 500 μl
fractions were collected from the bottom of the tube.
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